Vertex Pharmaceuticals is stopping development of VX-264, an experimental cell therapy/medical device treatment for type 1 diabetes, after an early look at Phase 1/2 data fell short of efficacy goals. This program came from a $950 million acquisition in 2019 that marked Vertex’s entry into type 1 diabetes. The post Vertex Cell Therapy Misses in…
Engaging in data sharing, observational cohort research, and deeper analysis of available data to yield further insights can drive improved results for patients, making label and cohort extension faster and more robust. The post How Real-World Data Can Support Label Extension And Safer Use Of Novel Therapies appeared first on MedCity News.
Two Chairs, which offers hybrid behavioral health care, expanded its presence from three states to 22 states. This expansion gives millions of people access to therapy services, as Two Chairs’ services are now available to 75% of the U.S. population. The post Two Chairs Expands Mental Health Services to 19 More States appeared first on…
A new report from the Private Equity Stakeholder Project reveals that private equity firms have been increasingly acquiring intellectual and developmental disability providers and implementing cost-cutting strategies that reduce care quality. The post What’s Private Equity’s Impact on Intellectual and Developmental Disability Services? appeared first on MedCity News.
The FDA granted marketing authorization to a Visby Medical at-home PCR test for three common sexually transmitted infections. The Visby test yields results in about 30 minutes. The post PCR Comes to the Home With FDA Authorization of Visby’s OTC Sexual Health Test appeared first on MedCity News.
It’s critical that healthcare organizations delivering on the program’s promise not be torpedoed by the “bad actors” The post The Case for 340B Done Right appeared first on MedCity News.
To reduce overdose rates in the U.S., leaders must recognize the impact of medication-assisted treatment in correctional facilities. The post Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional Settings appeared first on MedCity News.
Medicaid and SNAP cuts could lead to 1 million jobs lost in just 2026, according to a new report from the Commonwealth Fund and the George Washington University Milken Institute School of Public Health. The post Report: How Medicaid/SNAP Cuts Could Affect the Economy appeared first on MedCity News.
About 90% of healthcare organizations are insecurely connected to the internet and running systems vulnerable to exploitation by ransomware gangs, according to new research. It also found that 78% of providers have made ransomware payments of $500,000 or more. The post Most Healthcare Providers Remain Highly Vulnerable to Ransomware Attacks appeared first on MedCity News.
Novo Nordisk gets global rights to Lexicon Pharmaceuticals’ LX9851, an oral small molecule with a first-in-class approach to sparking weight loss. The licensing agreement comes months after Lexicon reported encouraging preclinical data from tests of LX9851 in combination with semaglutide, the main ingredient in Novo Nordisk’s Wegovy. The post Novo Nordisk Lands Lexicon Pharma Obesity…